PLAGL2 activates the EGFR/AKT signaling pathway and increases the expression of HIF-1α; this positive signaling loop enhances hypoxia, HCC growth, and metastasis [132]. The gene discussed is PLAGL2; the disease is hepatocellular carcinoma.